Effect of recombinant human growth hormone on regional tissue distribution in growth hormone-deficient males

Annals of the New York Academy of Sciences

Volumn 904, Issue , 2000, Pages 576-583

  Bell, W ^a   Davies, J S ^b   Evans, W D ^c   Scanlon, M F ^b  

^a CARDIFF METROPOLITAN UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE;

ADULT; ARM; BODY COMPOSITION; BODY FAT; BONE MASS; BONE MINERAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DUAL ENERGY X RAY ABSORPTIOMETRY; GROWTH HORMONE DEFICIENCY; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; TISSUE DISTRIBUTION; TRUNK;

EID: 0034084309     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06519.x     Document Type: Conference Paper

References (16)

1. BJORNTORP, P. 1987. Adipose tissue distribution and morbidity. In Recent Advances in Obesity Research, Vol. V.E.M. Berry, S.H. Blondheim, H.E. Eliahou & E. Shafrir, Eds.: 60-65. John Libbey. London.
2. KISSEBAH, A.H. & G.R. KRAKOWER. 1994. Regional adiposity and morbidity. Physiol. Rev. 74: 761-811.
3. CUNEO, R.C., F. SALOMON, G.A. MCGAULEY & P.H. SONKSEN. 1992. The growth hormone deficiency syndrome in adults. Clin. Endocrinol. 37: 387-397.
4. DE BOER, H., G-J. BLOK & E.A. VAN DER VEEN. 1995. Clinical aspects of growth hormone deficiency in adults. Endocr. Rev. 16: 63-86.
5. BELL, W., J.S. DAVIES, W.D. EVANS & M.F. SCANLON. 1999. Strength and its relationship to changes in fat-free mass, total body potassium, total body water and IGF-1 in adults with growth hormone deficiency: effect of treatment with growth hormone. Ann. Hum. Biol. 26: 63-78.
6. BELL, W., J.S. DAVIES, W.D. EVANS & M.F. SCANLON. 1995. The validity of estimating skinfold thickness in adults with growth hormone deficiency. J. Clin. Endocrinol. Metab. 80: 630-636.
7. LEWIS, M.K., G.M. BLAKE & I. FOGELMAN. 1994. Patient dose in dual X-ray absorptiometry. Osteopath. Int. 4: 209-218.
8. HERD, R.M.J., G.M. BLAKE, J.C. PARKER, P.J. RYAN & I. FOGELMAN. 1993. Total body studies in normal British women using dual energy X-ray absorptiometry. Brit. J. Radiol. 66: 303-308.
9. TAAFFE, D.R., B. LEWIS & R. MARCUS. 1994. Regional fat distribution by dual-energy X-ray absorptiometry: comparison with anthropometry and application in a clinical trial of growth hormone and exercise. Clin. Sci. 87: 581-586.
10. FORMICA, C.A. 1999. Total body bone mineral and body composition. In The Evaluation of Osteoporosis: Dual Energy X-ray Absorptiometry and Ultrasound in Clinical Practice. G.M. Blake, H.W. Wahner & I. Fogelman, Eds.: 313-345. Martin Dunitz. London.
11. KAUFMAN, J.-M. & M. VANDEWEGHE. 1996. Growth hormone (GH) therapy in GH deficient adults: effects on bone and mineral metabolism. In Growth Hormone in Adults. A. Juul & J.O.L. Jorgensen, Eds.: 252-282. Cambridge University Press. Cambridge.
12. LOHMAN, T.G. 1992. Advances in body composition assessment. Human Kinetics. Champaign, IL.
13. ROSEN, T., G. JOHANNSSON, P. HALLGREN, K. CAIDAHL, I. BOSAEUS & B.-A. BENGTSSON. 1994. Beneficial effects of 12 months replacement therapy with recombinant human growth hormone to growth hormone deficient adults. Endocrinol. Metab. 1: 55-66.
14. BESHYAH, S.A., O.M. RUTHERFORD, E. THOMAS, M. MURPHY & D.G. JOHNSTON. 1995. Assessment of regional body composition by dual energy X-ray absorptiometry in hypopituitary adults before and during growth hormone treatment. Endocrinol. Metab. 2: 147-155.
15. HEW, F.L., F.P. ALFORD, M. CHRISTOPHER, C. RANTZAU, M. KOSCHMANN, D. O'NEAL, G. WARD & J.D. BEST. 1996. Effects of growth hormone deficiency and therapy in adults on skeletal muscle glucose metabolism, lipid profiles and regional body composition. Endocrinol. Metab. 3(Suppl. A): 55-60.
16. WEAVER, J.U. & J.P. MONSON. 1993. Assessment of body fat distribution in adults with growth hormone deficiency. (Abstr.) Acta Endocrinol. 128(Suppl. 2): 68.